Literature DB >> 19009597

Conformational polymorphism in aripiprazole: Preparation, stability and structure of five modifications.

Doris E Braun1, Thomas Gelbrich, Volker Kahlenberg, Richard Tessadri, Josef Wieser, Ulrich J Griesser.   

Abstract

Five phase-pure modifications of the antipsychotic drug aripiprazole were prepared and characterized by thermal analysis, vibrational spectroscopy and X-ray diffractometry. All modifications can be produced from solvents, form I additionally by heating of form X degrees to approximately 120 degrees C (solid-solid transformation) and form III by crystallization from the melt. Thermodynamic relationships between the polymorphs were evaluated on the basis of thermochemical data and visualized in a semi-schematic energy/temperature diagram. At least six of the ten polymorphic pairs are enantiotropically and two monotropically related. Form X degrees is the thermodynamically stable modification at 20 degrees C, form II is stable in a window from about 62-77 degrees C, and form I above 80 degrees C (high-temperature form). Forms III and IV are triclinic ($P\overline 1$), I and X degrees are monoclinic (P2(1)) and form II orthorhombic (Pna2(1)). Each polymorph exhibits a distinct molecular conformation, and there are two fundamental N-H$\cdots$O hydrogen bond synthons (catemers and dimers). Hirshfeld surface analysis was employed to display differences in intermolecular short contacts. A high kinetic stability was observed for three metastable polymorphs which can be categorized as suitable candidates for the development of solid dosage forms. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19009597     DOI: 10.1002/jps.21574

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique.

Authors:  Tijana Mihajlovic; Kyriakos Kachrimanis; Adrijana Graovac; Zorica Djuric; Svetlana Ibric
Journal:  AAPS PharmSciTech       Date:  2012-04-26       Impact factor: 3.246

2.  Salt Engineering of Aripiprazole with Polycarboxylic Acids to Improve Physicochemical Properties.

Authors:  Hamideh Afrooz; Eman M Mohamed; Sogra F Barakh Ali; Sathish Dharani; Mohammad T H Nutan; Mansoor A Khan; Ziyaur Rahman
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

3.  Polymorphism in phenobarbital: discovery of a new polymorph and crystal structure of elusive form V.

Authors:  Saikat Roy; N Rajesh Goud; Adam J Matzger
Journal:  Chem Commun (Camb)       Date:  2016-03-21       Impact factor: 6.222

4.  Nonamorphism in flufenamic acid and a new record for a polymorphic compound with solved structures.

Authors:  Vilmalí López-Mejías; Jeff W Kampf; Adam J Matzger
Journal:  J Am Chem Soc       Date:  2012-06-12       Impact factor: 15.419

5.  4-Aminoquinaldine monohydrate polymorphism: Prediction and impurity aided discovery of a difficult to access stable form.

Authors:  Doris E Braun; Herbert Oberacher; Kathrin Arnhard; Maria Orlova; Ulrich J Griesser
Journal:  CrystEngComm       Date:  2015-10-15       Impact factor: 3.545

6.  7-Hy-droxy-1,2,3,4-tetra-hydro-quinolin-2-one dihydrate.

Authors:  Qian-Shou Zong; Jian-Yi Wu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-06-13

7.  Specific energy contributions from competing hydrogen-bonded structures in six polymorphs of phenobarbital.

Authors:  Thomas Gelbrich; Doris E Braun; Ulrich J Griesser
Journal:  Chem Cent J       Date:  2016-02-22       Impact factor: 4.215

8.  New Cocrystals of Antipsychotic Drug Aripiprazole: Decreasing the Dissolution through Cocrystallization.

Authors:  Wenwen Liu; Ru Ma; Feifei Liang; Chenxin Duan; Guisen Zhang; Yin Chen; Chao Hao
Journal:  Molecules       Date:  2021-04-21       Impact factor: 4.411

9.  Experimental and Computational Hydrate Screening: Cytosine, 5-Flucytosine and Their Solid Solution.

Authors:  Doris E Braun; Volker Kahlenberg; Ulrich J Griesser
Journal:  Cryst Growth Des       Date:  2017-06-13       Impact factor: 4.076

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.